It rose $2.01, placing it 24th among the top 50 biggest swings in Wall Street during the time frame.
Shares in H-Cyte Inc. finished the week ending Sept. 9 at $7.
H-Cyte Inc., based in Tampa, employs 26 people and has reported -$7,860,000 USD in income.
Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.
Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.
Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
| Company Name | Percentage Change | Current Trading Price |
|---|---|---|
| L S Starrett Co. | 1,871.9% | $8 |
| Strategic Acquisitions Inc. | 207.7% | $2 |
| ShiftPixy Inc. | 153.3% | $34.45 |
| Helo Corp. | 84.3% | $1.99 |
| Coherent Inc. | -83.4% | $44.23 |
| Imara Inc. | 81.7% | $2.09 |
| Spirits Time International Inc. | 75.7% | $2.6 |
| Digital Media Solutions Inc. | 66.7% | $2.2 |
| Intellinetics Inc. | 66.2% | $6.25 |
| HyreCar Inc. | 63.1% | $1.31 |
| Galera Therapeutics Inc. | 56.6% | $2.02 |
| ChannelAdvisor Corp. | 55.9% | $22.92 |
| Spero Therapeutics Inc. | 54.1% | $1.12 |
| SelectQuote Inc. | 50.5% | $1.43 |
| Petrocorp Inc. | 50% | $3 |
| Latch Inc. | 47.8% | $1.39 |
| Palatin Technologies Inc. | 47.4% | $6.78 |
| Presidio Property Trust Inc. | -47% | $1.67 |
| Invitae Corp. | 44.9% | $4 |
| Annovis Bio Inc. | 43.7% | $15.3 |
| Cleantech Acquisition Corp. | -42.5% | $6.1 |
| Terns Pharmaceuticals Inc. | 42% | $5.27 |
| Ecomax Inc. | 40.9% | $1.24 |
| H-Cyte Inc. | 40.3% | $7 |
| GeoVax Labs Inc. | 39% | $1.64 |
| Amyris Inc. | 37.7% | $3.76 |
| Vitaspring Biomedical Co. Ltd. | 37.5% | $15.1 |
| Eyenovia Inc. | 36.2% | $2.41 |
| Asana Inc. | 35.8% | $24.66 |
| Lifestance Health Group Inc. | 35.3% | $9.23 |
| Dyne Therapeutics Inc. | 34.6% | $14.91 |
| Golden Path Acquisition Corp. | -34.1% | $6.82 |
| RDE Inc. | 34% | $2.01 |
| Xilio Therapeutics Inc. | 32.9% | $2.75 |
| FalconStor Software Inc. | -32.9% | $1 |
| Cassava Sciences Inc. | 32.9% | $32.8 |
| Axcella Health Inc. | -32.7% | $1.75 |
| Fubotv Inc. | 31.1% | $4.43 |
| Revance Therapeutics Inc. | 31% | $28.47 |
| ThredUp Inc. | 30.8% | $2.89 |
| Taskus Inc. | 30.7% | $18.99 |
| Recursion Pharmaceuticals Inc. | 29.7% | $13.27 |
| Zscaler Inc. | 29.5% | $188 |
| Singular Genomics Systems Inc. | 29.5% | $3.25 |
| Acurx Pharmaceuticals Inc. | 29% | $4.36 |
| VirnetX Holding Corp. | -28.4% | $1.39 |
| Bioqual Inc. | 28% | $96 |
| PetIQ Inc. | 27.9% | $11.1 |
| Ipsidy Inc. | 27.8% | $3.36 |
| Artemis Therapeutics Inc. | 27.7% | $1.75 |
Alerts Sign-up